In the present study, elevations in myocardial oxidative stress and the gene expression level of anti-oxidant proteins in offspring with MFE treatment implied that an MFE-associated increase in myocardial oxidative stress may contribute to cardiac hypertrophy in adult offspring. The gene discussed is PROS1; the disease is cardiac hypertrophy.